Software tools for structure based rational drug design

被引:17
|
作者
Zsoldos, Z
Szabo, I
Szabo, Z
Johnson, AP
机构
[1] SimBioSys Inc, Toronto, ON M9W 6V1, Canada
[2] Univ Leeds, ICAMS, Leeds LS2 9JT, W Yorkshire, England
来源
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM | 2003年 / 666卷
关键词
rational drug design; ligand docking; de novo design; VHTS; scoring function;
D O I
10.1016/j.theochem.2003.08.105
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Scientific advancements during the past two decades have altered the way pharmaceutical research produces new bio-active molecules. Traditional 'trial and error' drug discovery efforts are gradually being replaced by structure based rational drug design. A key technique is the use of methods including X-ray crystallography and NMR for the determination of the 3-dimensional structure of a target protein followed by various modelling techniques for the design of small molecule ligands that could interact with the target structure. The first generation of the software tools were limited to energy calculations and molecular dynamics simulations based on simple force field models. More automated methods, like flexible ligand docking and de novo ligand design programs have emerged in the 90s. However, many of these software systems relied on stochastic algorithms to perform the search, effectively performing a computerised 'trial and error' search. SimBioSys provides ligand design and docking tools that are systematic, exhaustive, rely on rational rules, heuristics and dynamic knowledge bases. The novel algorithms designed and optimised to solve the specific problems greatly outperform the general random methods. The presentation gives a brief overview of the efficient algorithms behind the SPROUT (de novo ligand design) and eHiTS (flexible ligand docking and virtual high throughput screening) software tools. Validation test results are presented to demonstrate the effectiveness of these tools for the solution of practical drug design problems. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:659 / 665
页数:7
相关论文
共 50 条
  • [31] Structure-based drug design to augment hit discovery
    Kalyaanamoorthy, Subha
    Chen, Yi-Ping Phoebe
    DRUG DISCOVERY TODAY, 2011, 16 (17-18) : 831 - 839
  • [32] Structure-based approaches to drug design and virtual screening
    Waszkowycz, B
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2002, 5 (03) : 407 - 413
  • [33] Binding site matching in rational drug design: algorithms and applications
    Naderi, Misagh
    Lemoine, Jeffrey Mitchell
    Govindaraj, Rajiv Gandhi
    Kana, Omar Zade
    Feinstein, Wei Pan
    Brylinski, Michal
    BRIEFINGS IN BIOINFORMATICS, 2019, 20 (06) : 2167 - 2184
  • [34] Integrating structure-based and ligand-based approaches for computational drug design
    Wilson, Gregory L.
    Lill, Markus A.
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (06) : 735 - 750
  • [35] Progress in structure-based drug design against influenza A virus
    Du, Qi-Shi
    Wei, Hang
    Huang, Ri-Bo
    Chou, Kuo-Chen
    EXPERT OPINION ON DRUG DISCOVERY, 2011, 6 (06) : 619 - 631
  • [36] Experiences with the Shikimate-pathway enzymes as targets for rational drug design
    Coggins, JR
    Abell, C
    Evan, LB
    Frederickson, M
    Robinson, DA
    Roszak, AW
    Lapthorn, AP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 548 - 552
  • [37] In Silico Structure-Based Approach for Group Efficiency Estimation in Fragment-Based Drug Design Using Evaluation of Fragment Contributions
    Shulga, Dmitry A.
    Ivanov, Nikita N.
    Palyulin, Vladimir A.
    MOLECULES, 2022, 27 (06):
  • [38] A Review on Recent Rational Approaches to Drug Design, Development and Its Discovery
    Bisht, Dheeraj
    Arya, Rajeshwar Kamal Kant
    Pal, Govind Raj
    Singh, Ravindra Pratap
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, 10 (04): : P96 - P108
  • [39] Systems Biology Brings New Dimensions for Structure-Based Drug Design
    Pei, Jianfeng
    Yin, Ning
    Ma, Xiaomin
    Lai, Luhua
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (33) : 11556 - 11565
  • [40] TARGETING SERPINS IN HIGH-THROUGHPUT AND STRUCTURE-BASED DRUG DESIGN
    Chang, Yi-Pin
    Mahadeva, Ravi
    Patschull, Anathe O. M.
    Nobeli, Irene
    Ekeowa, Ugo I.
    McKay, Adam R.
    Thalassinos, Konstantinos
    Irving, James A.
    Haq, Imran
    Nyon, Mun Peak
    Christodoulou, John
    Ordonez, Adriana
    Miranda, Elena
    Gooptu, Bibek
    METHODS IN ENZYMOLOGY, VOL 501: SERPIN STRUCTURE AND EVOLUTION, 2011, 501 : 139 - 175